Navitus Asthma Management Program Gains National Attention for Delivering Health Improvement Outcome

July 7, 2015

MADISON, Wis., July 7, 2015– Navitus Health Solutions, LLC, a pharmacy benefit manager committed to improving population health, offers an Asthma Management Program that boasts positive health improvement outcomes for a highly prevalent, economically burdensome chronic condition. The program has secured national attention through awards, conference recognition and a recent peer reviewed publication.

In order to achieve its goal of improving member health at the lowest net cost, Navitus designs and implements evidence-based population health management programs. Ultimately, Navitus is in constant pursuit of translating science into practice to impact population health. The Asthma Management Program accomplishes this goal by using clinical algorithms to identify members with uncontrolled asthma and by providing actionable information to these members and their prescribers. The program seeks to ensure these members receive and properly use the correct medications.

For the Asthma Management Program, Navitus chose Asthma Medication Ratio (AMR) as the measurement for uncontrolled asthma, because ample support exists for its use as a quality of care indicator. When using pharmacy claims data for analyses, coupling the number of Short Acting Beta Agonist (SABA) prescriptions with AMR appears to be the most evidence-based method for identifying potentially uncontrolled asthmatic patients. Use of AMR also became a Healthcare Effectiveness Data and Information Set (HEDIS) measure in 2013. In 2010 (prior to the HEDIS measure), Navitus designed the program as an in-house application for member identification and outcome measurement.

In 2014, Navitus’ Asthma Management Program delivered 30-35 percent improvement in AMR to > 0.5 for clients participating in the program.

In May 2014, Clinical Scholars Review, a peer-reviewed journal, published an article written by Navitus titled “Outcome Evaluation of a Pharmacy Benefits Management based Asthma Management Program.” This article showed that a nurse-led PBM asthma management program of mailed educational interventions was effective in improving members’ AMRs. Specifically, the outcome evaluation project demonstrated statistically significant improvement in AMR and reduction in SABA claims at 12 months in the intervention group.

These encouraging outcomes have paved the way for Navitus receiving attention through poster and podium presentations at national conferences. In 2013, Navitus exhibited an outcome evaluation poster about the program at the Academy of Managed Care Pharmacy (AMCP) conference. The following year AMCP selected the program for a podium presentation and a platinum medal abstract. In 2015, Navitus presented a poster about the program at the Pharmacy Benefit Management Institute (PBMI) conference.

Navitus was also a finalist in the Disease Management/Population Health category for the Dorland Health Case-in-Point Platinum Award.

About Navitus

Navitus Health Solutions, LLC, a division of SSM Health, is a full-service, URAC-accredited pharmacy benefit management company. As a zero-spread, full pass through pharmacy benefit manager (PBM), Navitus aligns performance with plan sponsors’ benefit goals to deliver comprehensive clinical programs and cost-saving strategies that lower drug trend and promote good member health. Navitus provides its flexible services to government entities, self-funded employers, coalitions, labor organizations, third-party administrators, and health plans, including managed Medicaid, Exchanges, and Medicare Part D. For more information about Navitus’ tangible solutions to the rising cost of health care, visit www.navitus.com or call 877-571-7500.

For media inquiries, contact Amy Rohn of Lindsey, Stone & Briggs at 608-268-5332 or [email protected]

Stay Informed and Connected

Receive expert insights, healthcare tips, and important updates on pharmacy benefits, drug recalls, and more—straight to your inbox.

Examining Trends that Drive Informed Decisions

Now Available: 8th Annual Drug Trend Report

See the latest results and access industry insights you need to navigate current trend drivers.

Related blogs

Navigating Healthcare and Improving Outcomes

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Real-world Data Demonstrates Successful Transitions from Humira to Biosimilars

Authors: Justin Arzt, PharmD; Agata Siwak, PharmD, MSBA; Marnie Wickizer, PharmD, AE-C, CDCES; Ryan Schmidt, PharmD; Robert Topp, RN, PhD; Matt Hustad, PharmD All authors are employees of Navitus Health Solutions. Abstract Adalimumab biosimilar adoption…

PBM 101: Why the Model Matters

PBM 101: Why the Model Matters

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are conduits of expertise, analytics and savings opportunities, poised to deliver exceptional health care while driving down costs. They coordinate between drug manufacturers,…

Associate Resource Group Spotlight: Green Team

Associate Resource Group Spotlight: Green Team

The Green Team believes that small changes lead to significant impact. Whether its reducing waste, conserving energy or implementing eco-friendly initiatives, they serve as an internal hub for expertise regarding environmental sustainability….

PBM 101: The Three PBM Business Models

PBM 101: The Three PBM Business Models

In the pharmaceutical and healthcare industry, pharmacy benefit managers (PBMs) are regarded by the media as intermediaries between drug manufacturers, pharmacies, health plans and plan sponsors. But they’re so much more than that. PBMs act as conduits…

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

An Automated Approach to Diagnosis Verification of GLP-1 RA for Type 2 Diabetes Mellitus (T2DM)

This study examines the impact of implementing an automated point-of-sale diagnosis verification system for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) compared to traditional utilization management approaches….

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

Navitus to Remove Stelara® from Formulary July 1, 2025, Adds Biosimilars to Drive $120 Million in Savings 

As the nation’s first 100% transparent, pass-through PBM, we continue to advance medication affordability by prioritizing upfront, real-time savings over rebated models….

Achieving Outstanding Results with Tailored Network Strategies

Achieving Outstanding Results with Tailored Network Strategies

A medium-sized city in Michigan with 1,350 members was seeking ways to lower its pharmacy benefit costs, which were growing under its existing traditional pharmacy benefit manager (PBM). With its member covered by a two-tier, open formulary including…

Breaking Through Barriers with Value-Based Plan Design

Breaking Through Barriers with Value-Based Plan Design

Facing increased pharmacy benefit expenses, Blain’s Farm and Fleet, a Midwestern employer group, desired to improve plan performance. Specifically it was interested in educating eligible members about the benefits available to them, promoting cost-effective…

Finding a Solution to Lower Prescription Drug Costs

Finding a Solution to Lower Prescription Drug Costs

The Rural Arizona Group Health Trust (RAGHT) wanted to gain better control of its escalating drug trend with its large, traditional pharmacy benefit manager (PBM). Having only worked with traditional PBMs in the past, RAGHT was interested in exploring…

previous arrow
next arrow